Banque Cantonale Vaudoise - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.

Quarter-by-quarter ownership
Banque Cantonale Vaudoise ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$45,000
-30.8%
1,167
+2.5%
0.00%
-33.3%
Q1 2022$65,000
-28.6%
1,1390.0%0.00%
-25.0%
Q4 2021$91,000
-8.1%
1,1390.0%0.00%0.0%
Q3 2021$99,000
-23.3%
1,139
+13.9%
0.00%
-33.3%
Q2 2021$129,000
+61.2%
1,0000.0%0.01%
+50.0%
Q1 2021$80,000
-2.4%
1,0000.0%0.00%
-20.0%
Q4 2020$82,000
+228.0%
1,0000.0%0.01%
+150.0%
Q3 2020$25,0001,0000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders